Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies (Q42688053)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 1, 2011

Language	Label	Description	Also known as
English	Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies	scientific article published on February 1, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies (English)

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21277674

23 November 2024

author name string

Leena Anttila

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Gloria Bachmann

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

László Hernádi

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Michael Kunz

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Joachim Marr

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Christine Klipping

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21277674

23 November 2024

publication date

1 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0301211511000182?httpAccept=text/xml

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

https://api.elsevier.com/content/article/PII:S0301211511000182?httpAccept=text/plain

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

European Journal of Obstetrics Gynecology and Reproductive Biology

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

155

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

180-182

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone

1

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen.

2

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive

3

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

A comparison of the cycle control, safety, and efficacy profile of a 21-day regimen of ethinylestradiol 20mug and drospirenone 3mg with a 21-day regimen of ethinylestradiol 20mug and desogestrel 150mug

4

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism

5

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder

6

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation

7

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 microg and ethinyl estradiol 20 microg

11

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Large observational trial of a new low-dose oral contraceptive containing 20 micrograms ethinylestradiol and 100 micrograms levonorgestrel (Miranova) in Germany

12

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene

13

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).

14

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group

15

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Shorter pill-free interval in combined oral contraceptives decreases follicular development

16

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Greater inhibition of the pituitary--ovarian axis in oral contraceptive regimens with a shortened hormone-free interval

17

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity

18

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen

19

1 reference

10.1016/J.EJOGRB.2010.12.037

https://api.crossref.org/works/10.1016/J.EJOGRB.2010.12.037

23 November 2024

Identifiers

10.1016/J.EJOGRB.2010.12.037

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42688053&oldid=2278569531"